|
|
|
|
LEADER |
01479cam a2200385 4500 |
001 |
PPN048295434 |
003 |
http://www.sudoc.fr/048295434 |
005 |
20230508055700.0 |
035 |
|
|
|a (OCoLC)496182108
|
035 |
|
|
|a sib1509841
|
100 |
|
|
|a 20000225d1965 k y0frey0103 ba
|
101 |
0 |
|
|a eng
|2 639-2
|
102 |
|
|
|a US
|
105 |
|
|
|a a z 001yy
|
106 |
|
|
|a r
|
181 |
|
|
|6 z01
|c txt
|2 rdacontent
|
181 |
|
1 |
|6 z01
|a i#
|b xxxe##
|
182 |
|
|
|6 z01
|c n
|2 rdamedia
|
182 |
|
1 |
|6 z01
|a n
|
183 |
|
|
|6 z01
|a nga
|2 RDAfrCarrier
|
200 |
1 |
|
|a The pharmacopeia of the United States of America (The United States pharmacopeia)
|e Official from September 1, 1965
|f by authority of the United States Pharmacopeial Convention, Inc., meeting at Washinton, D. C., March 29 and 30, 1960
|g prepared by the Committee of Revision and published by the Board of Trustees
|
205 |
|
|
|a Seventeenth revision
|
214 |
|
0 |
|a Rockville Md
|c United States Pharmacopeial Convention
|d 1965
|
215 |
|
|
|a 1 vol. (lxvi-1156 p.)
|c ill.
|d 23 cm
|
320 |
|
|
|a Index
|
516 |
| |
|
|a U.S.P. XVII
|
517 |
| |
|
|a The United States Pharmacopoeia
|
606 |
|
|
|3 PPN030943736
|a Pharmacopée
|3 PPN027225488
|y États-Unis
|2 rameau
|
606 |
|
|
|3 PPN040839958
|a Pharmacopée
|3 PPN040795837
|x États-Unis
|2 fmesh
|
712 |
0 |
2 |
|3 PPN058648402
|a United States pharmacopeial convention
|4 340
|
801 |
|
3 |
|a FR
|b SF
|g AFNOR
|
801 |
|
3 |
|a FR
|b Abes
|c 20230505
|g AFNOR
|
930 |
|
|
|5 441092101:78794243X
|b 441092101
|j u
|
979 |
|
|
|a SAN
|
998 |
|
|
|a 942584
|